J Thorac Cardiovasc Surg 2009;138:8
© 2009 The American Association for Thoracic Surgery
Uric acid levels and outcomes from coronary artery bypass grafting: Is it the chicken or the egg?
Harold L. Lazar, MD*
Boston Medical Center, Boston, Mass
Received for publication January 21, 2009; revisions received February 20, 2009; accepted for publication March 7, 2009.
* Address for reprints: Harold L. Lazar, MD, Boston Medical Center, Cardiothoracic Surgery, 88 E. Newton St, Suite B 404, Boston, MA 02118. (Email: harold.lazar@bmc.org).
| The first 20% of the full text of this article appears below. |
| See related article on page 200.
|
Elevated uric acid levels are associated with risk factors common to patients who require coronary artery bypass graft (CABG) surgery. In this edition of the Journal, Hills and coworkers now propose that hyperuricemia may also be an independent risk factor for adverse events after CABG surgery.1
In this single-center, retrospective series, the authors have shown that patients with hyperuricemia undergoing isolated, nonemergency surgery have a higher incidence of mortality over a 3-year period. Hyperuricemia has been associated with adverse cardiovascular events in patients with atherosclerotic disease.2
Furthermore, it has . . . [Full Text of this Article]
Related Article
-
Uric acid levels and outcome from coronary artery bypass grafting
- Graham S. Hillis, Brian H. Cuthbertson, Patrick H. Gibson, Jane D. McNeilly, Graeme S. Maclennan, Robert R. Jeffrey, Keith G. Buchan, Hussein El-Shafei, George Gibson, and Bernard L. Croal
J. Thorac. Cardiovasc. Surg. 2009 138: 200-205.
[Abstract]
[Full Text]
[PDF]
Copyright © 2009 by The American Association for Thoracic Surgery.